SCRIP
World Pharmaceutical News
Issue No 2763
July 12th 2002

A new German drug development consultancy, Aspiras:

A new German consultancy, Aspiras, has been set up in Mainz to facilitate drug development project management, including setting up research collaborations, the evaluation of financial issues and interacting with regulatory authorities. Aspiras includes co-founder Cathrin Pauly, who has previously worked at Asta Medica, Rhône-Poulenc, Madaus and Schwarz, Dr Thomas Wittlinger, a specialist in internal medicine and cardiology, Dr Ute Rehwald, who has experience in preclinical and clinical development of biotech products, and Andreas Bartsch, a financial planning expert. Further details can be viewed on: www.aspiras.de.